These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3975874)

  • 1. Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity.
    Cavanaugh PG; Sloane BF; Bajkowski AS; Taylor JD; Honn KV
    Thromb Res; 1985 Jan; 37(2):309-26. PubMed ID: 3975874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
    Pearlstein E; Ambrogio C; Gasic G; Karpatkin S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4535-9. PubMed ID: 7306974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerastotin, a serine protease from Cerastes cerastes venom, with platelet-aggregating and agglutinating properties.
    Marrakchi N; Barbouche R; Guermazi S; Karoui H; Bon C; El Ayeb M
    Eur J Biochem; 1997 Jul; 247(1):121-8. PubMed ID: 9249017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
    Chen SH
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine tumor-induced platelet aggregation and coagulation: mechanisms, inhibitors, and species differences.
    Panton RW; Agarwal KC; Robison BS; Parks RE
    Thromb Res; 1987 Apr; 46(1):65-76. PubMed ID: 3590114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bothrops jararaca snake venom: effects on platelet aggregation.
    Zingali RB; Carlini CR; Francischetti IM; Guimarães JA
    Thromb Res; 1990 May; 58(3):303-16. PubMed ID: 2353342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom.
    Fonseca FV; Antunes E; Morganti RP; Monteiro HS; Martins AM; Toyama DO; Marangoni S; Toyama MH
    Protein J; 2006 Apr; 25(3):183-92. PubMed ID: 16729248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.
    Pearlstein E; Ambrogio C; Gasic G; Karpatkin S
    Prog Clin Biol Res; 1982; 89():479-502. PubMed ID: 6287488
    [No Abstract]   [Full Text] [Related]  

  • 9. The purification and properties of cancer procoagulant from murine tumors.
    Moore WR
    Biochem Biophys Res Commun; 1992 Apr; 184(2):819-24. PubMed ID: 1575750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk.
    Ishii H; Hiraishi S; Kazama M
    Thromb Res; 1982 Oct; 28(1):85-92. PubMed ID: 6897588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of porcine platelet aggregating factor.
    Marcus DL; Johnson AJ; Finlay TH
    Biochim Biophys Acta; 1978 Nov; 537(1):44-61. PubMed ID: 718981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.
    Karpatkin S; Pearlstein E; Salk PL; Yogeeswaran G
    Prog Clin Biol Res; 1982; 89():445-77. PubMed ID: 7111309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis.
    Cavanaugh PG; Sloane BF; Honn KV
    Haemostasis; 1988; 18(1):37-46. PubMed ID: 3047022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis.
    Bastida E; Ordinas A; Escolar G; Jamieson GA
    Blood; 1984 Jul; 64(1):177-84. PubMed ID: 6733271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A factor X-activating cysteine protease from malignant tissue.
    Gordon SG; Cross BA
    J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
    Greco NJ; Tenner TE; Tandon NN; Jamieson GA
    Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, characterization, and amino acid sequence of a serine proteinase, PA-BJ, with platelet-aggregating activity from the venom of Bothrops jararaca.
    Serrano SM; Mentele R; Sampaio CA; Fink E
    Biochemistry; 1995 May; 34(21):7186-93. PubMed ID: 7766629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP
    Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet aggregation due to plasma-aggregating activity. Identification of the responsible factors.
    Serneri GG; Abbate R; Mugnaini C; Gensini GF
    Haemostasis; 1980; 9(3):141-156. PubMed ID: 6768658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procoagulant and platelet aggregating properties of antilymphocyte sera.
    Kimball DB; Rickles FR; Gockerman JP; Hattler BG; Light JA; Conrad ME
    J Lab Clin Med; 1976 May; 87(5):868-81. PubMed ID: 1270893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.